Jennifer L. Good, President & CEO at Trevi Therapeutics, Inc. (TRVI), sold 95,398 shares at $3.11 ($295K) on 2024-09-05, disclosed to the SEC on 2024-09-05.
Open-market sale of $295k TRVI by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.02 | 3,863 | $12K | 3.9% |
| 2 | $3.02 | 10,981 | $33K | 11.2% |
| 3 | $3.11 | 40,277 | $125K | 42.4% |
| 4 | $3.11 | 40,277 | $125K | 42.4% |
| Total | $3.10 avg | 95,398 | $295K | 100% |
| Filing → |
| RYTM | SELL | 2024-09-11 | $3.8M | — | Filing → |
| TRVI | SELL | 2024-09-09 | $18K | — | Filing → |
| RYTM | SELL | 2024-08-28 | $1.5M | — | Filing → |